Company News
Qingdao Haoen: Pioneering Medical Packaging Solutions with Global Compliance
Innovation-Driven | ISO/GMP Certified | Serving 50+ Countries
Qingdao, China – June 30, 2025 – Qingdao Haoen Pharmaceutical Consumable Co., Ltd., a high-tech enterprise specializing in advanced medical packaging since 2008, today reaffirms its commitment to revolutionizing pharmaceutical safety and sustainability through cutting-edge material science and intelligent manufacturing. With 32 patents granted in 2024–2025 alone—including breakthroughs in fragmentation-free infusion caps and biodegradable barriers—Haoen sets new benchmarks for aseptic drug containment worldwide .
Core Capabilities & Technological Leadership
Advanced Manufacturing Infrastructure
12,000㎡ ISO Class 8 Cleanroom: Ensures sterile production of infusion caps, connectors, and plastic vials compliant with USP <661> and EP 10.0 standards .
DMT Energy Management System: AI-driven production monitoring reduces carbon footprint by 18% while optimizing resource efficiency, developed in partnership with Rongshang IoT (2018) .
Material Innovation
Eco-Medical Polymers: Proprietary bio-based PP/PE resins (30% sugarcane-derived) align with EU Single-Use Plastics Directive (SUPD), offering autoclavable stability (121°C/30min) and recyclability rates exceeding 95% .
High-Barrier Coatings: Multi-layer co-extrusion technology achieves WVTR <0.01 g·mm/m²·day, extending drug shelf life without refrigeration .
Global Compliance & Strategic Growth
Certifications: ISO 13485, FDA 21 CFR 177.1520, CE, and China NMPA YBB certifications validate zero-leakage performance (-20kPa~+60kPa per ASTM D4991-07) .
Vertical Integration: Three specialized subsidiaries cover hollow packaging systems, medical devices, and import-export operations, enabling 30% faster lead times for customized orders (Φ19mm–Φ50mm diameters) .
Global Footprint: Products deployed across 50+ countries with clinical partners reporting 37% reduction in hospital-acquired infections via Haoen’s dual-port infusion closures .
2025 Milestones & Vision
R&D Expansion: New “Medical Plastic R&D Center” with Sichuan University focuses on smart packaging (e.g., NFC temperature-tracking vial caps) .
Sustainability Pledge: Target 50% PCR-PP usage by 2026 and carbon-neutral logistics via partnerships with UPS Healthcare Precision Logistics .
CEO Li Shuping states:
“Our mission is to merge precision engineering with ecological responsibility. With 80+ patents and collaborations with academic giants like Qingdao University of Science and Technology, we empower pharmaceutical brands to deliver safer therapies while advancing circular economy goals.”
Explore Our Innovations:
Infusion Portfolio: Double-break caps | Needle-free connectors | Hermetic vial closures
Certification Hub: Download test reports for USP, EP, and ISO 11607 compliance
About Qingdao Haoen
Founded in 2008 and headquartered in Jimo District, Qingdao, Haoen operates with 4000㎡ R&D facilities and serves 200+ global clients. As a National Specialized & Sophisticated SME, it holds 82 patents and 15 production licenses for medical packaging .
Media Contact:
huangjianhao1227@gmail.com
| +86-178 639 55588
Add: No. 6 Fuda Road, Daxin Town, Jimo, Qingdao, China 266234